Research and Development

The Research and Development team at Allakos is dedicated to advancing the company's therapeutic antibody pipeline by conducting in-depth scientific research and development activities. This team focuses on identifying and characterizing antibodies that specifically target eosinophils and mast cells, while also overseeing drug product formulation and clinical development. By leveraging expertise in protein sciences, regulatory affairs, and cell line development, they play a crucial role in bringing innovative treatments to patients with eosinophil- and mast cell-related diseases.